GC to stop making 1st thrombolytic agent amid poor sales - Korea Biomedical Review

GC to stop making 1st thrombolytic agent amid poor sales  Korea Biomedical Review

GC will stop manufacturing Urokinase, Korea's first thrombolytic agent, after 45 years of its launch due to sluggish sales. Urokinase has indications in treating ...